These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 31314884)
1. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis. Hart L; Chavannes M; Kherad O; Maedler C; Mourad N; Marcus V; Afif W; Bitton A; Lakatos PL; Brassard P; Bessissow T J Crohns Colitis; 2020 Jan; 14(1):46-52. PubMed ID: 31314884 [TBL] [Abstract][Full Text] [Related]
2. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease. Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408 [TBL] [Abstract][Full Text] [Related]
3. Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission. Kawashima K; Oshima N; Kishimoto K; Kataoka M; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Kazumori H; Ishikawa N; Araki A; Ishihara S Inflamm Bowel Dis; 2023 Mar; 29(3):359-366. PubMed ID: 35583193 [TBL] [Abstract][Full Text] [Related]
4. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374 [TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study. Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ; Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815 [No Abstract] [Full Text] [Related]
7. Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores. Shi HY; Chan FKL; Chan AWH; Higashimori A; Kyaw M; Ching JYL; Luk AKC; Wong SH; Wu JCY; Sung JJY; Ng SC J Crohns Colitis; 2017 Sep; 11(9):1071-1077. PubMed ID: 28881876 [TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121 [TBL] [Abstract][Full Text] [Related]
9. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Karling P; Lundgren D; Eklöf V; Palmqvist R; Hultdin J Scand J Clin Lab Invest; 2019 Sep; 79(5):341-346. PubMed ID: 31164011 [TBL] [Abstract][Full Text] [Related]
10. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483 [TBL] [Abstract][Full Text] [Related]
11. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis. Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422 [TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis. Malvão LDR; Madi K; Esberard BC; de Amorim RF; Silva KDS; Farias E Silva K; de Souza HSP; Carvalho ATP Medicine (Baltimore); 2021 Jan; 100(3):e24058. PubMed ID: 33546007 [TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346 [TBL] [Abstract][Full Text] [Related]
14. Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients. Cannatelli R; Bazarova A; Zardo D; Nardone OM; Shivaji U; Smith SCL; Gkoutos G; Ricci C; Gui XS; Ghosh S; Iacucci M Inflamm Bowel Dis; 2021 Apr; 27(5):647-654. PubMed ID: 32592477 [TBL] [Abstract][Full Text] [Related]
15. Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1. Reinisch W; Bressler B; Curtis R; Parikh A; Yang H; Rosario M; Røseth A; Danese S; Feagan B; Sands BE; Ginsburg P; Dassopoulos T; Lewis J; Xu J; Wyant T Inflamm Bowel Dis; 2019 Mar; 25(4):803-810. PubMed ID: 30295811 [TBL] [Abstract][Full Text] [Related]
16. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Shentova R; Baycheva M; Hadjiiski P; Kofinova D; Yaneva P Gastroenterol Hepatol; 2020 Jan; 43(1):57-61. PubMed ID: 31733888 [TBL] [Abstract][Full Text] [Related]
17. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study. Shimoyama T; Yamamoto T; Umegae S; Matsumoto K BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300 [TBL] [Abstract][Full Text] [Related]
18. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis. Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study. Magro F; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Torres J; Dias CC; Lopes J; Borralho P; Afonso J; Geboes K; Carneiro F; J Crohns Colitis; 2017 Apr; 11(4):435-444. PubMed ID: 27664275 [TBL] [Abstract][Full Text] [Related]
20. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis. Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]